NOP53 and brain neoplasm: NOP53, considered a tumor suppressor in brain tumor cells [127,128], is overexpressed after treatment with paclitaxel and bevacizumab, and NOP53 silencing decrease sensitivity to bevacizumab in SKOV-3 cells.